Yan Yang The Jackson Laboratory, Bar Harbor, ME|
|Participants||Yang Y, Rodriguez T|
|Contact||Yan Yang email@example.com
|Affiliated Center||JAX In Vivo Services|
|MPD identifiers||Jaxwest8 MPD:328|
|No updates/corrections. Initial release date: 06/2009.|
Click above to copy-paste the entire citation for this MPD web page.
Purpose: The objective of this study was to assess the therapeutic potential of a novel compound (L-DOPA) to inhibit the onset and progression of cell loss and development of Parkinsonian pathology in an acute model of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson Disease using using 9-wk-old C57BL/6J male mice.
By posting this data, JAX® In Vivo Services contributes to community research resources and fulfills an agreement with clients to make normative data public.
Investigator's notes and website:
Compound evaluation services: Chronic MPTP Model of Parkinson’s Disease